Pharmacological hypothesis: Nitric oxide-induced inhibition of ADAM-17 activity as well as vesicle release can in turn prevent the production of soluble endothelin-converting enzyme.
Pharmacol Res Perspect
; 5(5)2017 10.
Article
em En
| MEDLINE
| ID: mdl-28971608
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Enzimas Conversoras de Endotelina
/
Proteína ADAM17
/
Óxido Nítrico
Limite:
Animals
/
Humans
Idioma:
En
Revista:
Pharmacol Res Perspect
Ano de publicação:
2017
Tipo de documento:
Article